Quotient: Flagship, Quotient and Pfizer link on cardiovascular and renal disease
Flagship Pioneering and Quotient Therapeutics have partnered with Pfizer to identify new targets for cardiovascular and renal diseases.
Read full article »
Quotient is a Massachusetts-based somatic genomics platform that provides solutions such as sequencing and phenotyping for the pharmaceutical sector.
Read more